mortality/aging
• mice die at mid-to-late gestation stages; no live-born mice are observed
|
cardiovascular system
• in the venous system in the lung and liver at E14.5
|
• at E14.5
|
• at E14.5
|
• in the ventricular and atrial chamber wall at E10.5
• in the heart at E14.5 and E16.5
• however, glycogen accumulation in the liver and skeletal muscle is normal
|
• at E12.5 and at E13.5
|
• at E12.5, ventricular compaction is reduced compared to in wild-type mice
• at E16.5, ventricles exhibit hypertrabeculation and noncompaction compared to in wild-type mice
|
• thin at E13.5 with a looser structure than in wild-type mice
• at E15.5, mice exhibit frank ventricular defects compared with wild-type mice
|
• in E15.5, E16.5, and stillborn mice
|
• hyperproliferation at E16.5
|
• E10.5
|
homeostasis/metabolism
• in the ventricular and atrial chamber wall at E10.5
• in the heart at E14.5 and E16.5
• however, glycogen accumulation in the liver and skeletal muscle is normal
|
liver/biliary system
• at E14.5
|
respiratory system
• at E14.5
|
muscle
• in the ventricular and atrial chamber wall at E10.5
• in the heart at E14.5 and E16.5
• however, glycogen accumulation in the liver and skeletal muscle is normal
|
• at E12.5 and at E13.5
|
• hyperproliferation at E16.5
|
cellular
• hyperproliferation at E16.5
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
glycogen storage disease IV | DOID:2750 |
OMIM:232500 |
J:167233 |